Target intelligence / Profile preview

High affinity immunoglobulin epsilon receptor subunit gamma (FcεRIγ)

Target
FcεRIγ
Molecular classification
Receptor (subunit of high-affinity IgE receptor), Adapter protein (contains ITAM motif), Transmembrane signaling protein
01

Overview

The **high affinity immunoglobulin epsilon receptor subunit gamma** (FcεRIγ) is an essential component of the tetrameric high-affinity IgE receptor complex (FcεRI), which consists of one alpha chain (IgE-binding), one beta chain (signal amplification), and two disulfide-linked gamma chains. The **gamma chains** contain immunoreceptor tyrosine-based activation motifs (*ITAMs*) that initiate intracellular signaling cascades upon antigen-induced crosslinking via bound IgE. This leads to rapid degranulation of mast cells or basophils—central events in immediate-type hypersensitivity reactions such as allergies. Beyond its role in allergy, **FcεRIγ** also serves as a common adapter/signaling module for other activating immune receptors including those recognizing other antibody classes (*e.g.*, certain FcγRs). It participates broadly in innate immunity through interactions with pattern recognition receptors on myeloid cells. Mutations or dysregulation can contribute to various pathologies involving abnormal inflammation or impaired host defense. The gene encoding this protein is *FCER1G*; it is expressed primarily on mast cells, basophils, eosinophils, Langerhans cells, some dendritic cell subsets—and inducibly elsewhere during inflammation. Its centrality makes it both a therapeutic target and a biomarker candidate for allergic diseases.

Other names
Fc epsilon RI gamma chainFCER1GIgE Fc receptor gamma subunitFcRγFceR1-gamma chain
02

Mechanism of action

Drugs like omalizumab prevent crosslinking of FcεRI by neutralizing circulating IgE. This inhibits downstream signal transduction through the gamma subunits' ITAM motifs, blocking mast cell/basophil degranulation and release of inflammatory mediators.

03

Biological functions

Signal transduction for immune receptorsMediates allergic inflammatory signaling in mast cells and basophilsParticipates in activation of antigen-presenting cells and T-cell priming toward Th1, Th2, and Th17 subsetsInvolved in integrin-mediated neutrophil and platelet activation
04

Disease associations

Allergy/Allergic reactions (e.g., asthma, atopic dermatitis)Inflammation
05

Safety considerations

Therapeutic targeting may risk immunosuppression or altered host defense against parasites due to broad roles in immune cell activationoff-target effects are possible given shared use of this subunit among multiple immune receptorsThere is also potential for hypersensitivity reactions.
06

Interacting drugs

Omalizumab is a monoclonal antibody that targets the IgE-FcεRI interaction by binding to free IgE, thereby preventing its association with the high-affinity receptor complex. While it does not directly bind the gamma subunit, it functionally modulates the entire complex's activity by reducing available IgE for crosslinking.
07

Biomarkers

Elevated expression or activation status of FcεRI on basophils/mast cells can serve as a biomarker for allergic disease activity or response to anti-IgE therapy such as omalizumab.

Beyond the preview

Go deeper on High affinity immunoglobulin epsilon receptor subunit gamma (FcεRIγ).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on High affinity immunoglobulin epsilon receptor subunit gamma (FcεRIγ).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call